BNC Wealth Management’s Zimmer Biomet ZBH Stock Holding History

BNC Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-41	Closed	-$5K	–	479
2020 Q3	$5K	Buy	+41	New	+$5.36K	﹤0.01%	378

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BNC Wealth Management's ZBH Position: Q4 2020 in Review

BNC Wealth Management sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 41 shares — an estimated $5K sold.

BNC Wealth Management first reported a position in ZBH in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

BNC Wealth Management reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
BNC Wealth Management sold 41 Zimmer Biomet shares in Q4 2020, an estimated $5K.
BNC Wealth Management first reported a position in Zimmer Biomet in Q3 2020 and held it in 1 quarter.
BNC Wealth Management's Zimmer Biomet position peaked at $5K in Q3 2020.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.